Common Stock, Shares, Outstanding of Actinium Pharmaceuticals, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Actinium Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Actinium Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 31,195,891, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Actinium Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 31,195,891 0 0% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 31,195,891 +645,289 +2.1% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 31,195,891 +1,799,480 +6.1% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 31,195,891 +3,561,678 +13% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 31,195,891 +3,782,450 +14% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 30,550,602 +3,566,159 +13% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 29,396,411 +3,667,041 +14% 31 Mar 2024 10-Q 26 Apr 2024 2024 Q1
Q4 2023 27,634,213 +1,959,390 +7.6% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 27,413,441 +2,201,369 +8.7% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 26,984,443 +2,113,820 +8.5% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 25,729,370 +3,585,396 +16% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 25,674,823 +3,530,849 +16% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 25,212,072 +3,181,234 +14% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 24,870,623 +3,779,692 +18% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 22,143,974 +2,898,336 +15% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 22,143,974 +4,611,081 +26% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 22,030,838 +8,444,313 +62% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 21,090,931 +7,919,107 +60% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 19,245,638 -155,593,898 -89% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 17,532,893 +12,042,855 +219% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 13,586,525 -151,114,642 -92% 30 Sep 2020 10-Q 23 Oct 2020 2020 Q3
Q2 2020 13,171,824 -148,861,697 -92% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 174,839,536 +55,703,500 +47% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 5,490,038 -110,213,006 -95% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 164,701,167 +54,232,214 +49% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 162,033,521 +51,575,400 +47% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 119,136,036 +8,819,308 +8% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 115,703,044 +35,630,710 +44% 31 Dec 2018 10-K 08 May 2020 2019 FY
Q3 2018 110,468,953 +30,443,314 +38% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 110,458,121 +51,939,048 +89% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 110,316,728 +53,164,329 +93% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 80,072,334 +24,270,592 +43% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 80,025,639 +32,279,531 +68% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 58,519,073 +11,225,849 +24% 30 Jun 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 57,152,399 +12,227,223 +27% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 55,801,742 +11,735,201 +27% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 47,746,108 +5,828,705 +14% 30 Sep 2016 10-Q 28 Oct 2016 2016 Q3
Q2 2016 47,293,224 +6,806,348 +17% 30 Jun 2016 10-Q 29 Jul 2016 2016 Q2
Q1 2016 44,925,176 +9,219,863 +26% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 44,066,541 +14,094,702 +47% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 41,917,403 +12,297,908 +42% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 40,486,876 +12,884,684 +47% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 35,705,313 +10,142,967 +40% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 29,971,839 +5,406,392 +22% 31 Dec 2014 10-K 11 Mar 2016 2015 FY
Q3 2014 29,619,495 +5,962,913 +25% 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 27,602,192 +4,017,768 +17% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 25,562,346 +4,170,681 +19% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 24,565,447 +3,173,782 +15% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 23,656,582 +12,501,574 +112% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 23,584,424 +12,429,416 +111% 30 Jun 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 21,391,665 +10,236,657 +92% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 21,391,665 +7,726,863 +57% 31 Dec 2012 10-K 28 Feb 2014 2013 FY
Q3 2012 11,155,008 0 0% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 11,155,008 0 0% 30 Jun 2012 10-Q/A 29 Aug 2012 2012 Q2
Q1 2012 11,155,008 31 Mar 2012 10-Q 23 Apr 2012 2012 Q1
Q4 2011 13,664,802 +2,509,794 +22% 31 Dec 2011 10-K 29 Mar 2013 2012 FY
Q3 2011 11,155,008 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 11,155,008 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 11,155,008 31 Dec 2010 10-K 12 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.